IceCure Medical Sees Strong Demand in US, European Sales Record

• IceCure Medical reports strong US demand following FDA marketing authorization. • European sales record driven by positive US clearance effects and growing adoption. • Record number of peer-reviewed publications and presentations for ProSense cryoablation. • Company addresses a market opportunity of approximately 200,000 patients in the US.